Avapritinib in PDGFRA D842V GIST By LRG Staff|2021-03-30T14:17:27-04:00March 30th, 2021|Global, Video| This video deals with the mechanism of avapritinib in GIST, current outcomes and challenges with PDGFRA D842V mutated GIST. watch replay Related Posts European Patient Cancer Coalition Publishes Patient Guide for Cancer Biomarkers European Patient Cancer Coalition Publishes Patient Guide for Cancer Biomarkers January 27th, 2023 Global Advocacy News – SIMPOSIO ONCOLATINO Global Advocacy News – SIMPOSIO ONCOLATINO September 9th, 2022 Life Fest 2022: The Role of Surgery in GIST Treatment/Neoadjuvant & Adjuvant Therapy Life Fest 2022: The Role of Surgery in GIST Treatment/Neoadjuvant & Adjuvant Therapy August 10th, 2022 Life Fest 2022: Management of GIST & Treatment-related Symptoms Life Fest 2022: Management of GIST & Treatment-related Symptoms August 10th, 2022 Life Fest 2022: GISTs Surgery Basics Life Fest 2022: GISTs Surgery Basics August 10th, 2022